India Army Report issue

Government Phase 2 Phase 3

Organization Overview

First Clinical Trial
2008
NCT01501773
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Army Research and Referral hospital | Army R&R Hospital, New Delhi

Active Ingredients

Drugs in Phase 3 Trials (1)

tadalafil (cialis) (1 trial)

Drugs in Phase 2 Trials (1)

allogeneic adipose derived mesenchymal stem cell (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Raynaud Disease (Phase 3)

Scleroderma, Diffuse (Phase 3)

Scleroderma, Localized (Phase 3)

Scleroderma, Systemic (Phase 3)

Stroke (Phase 2)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2